title: Rheumatoid vasculitis treated with infliximab.
abstract: We describe a patient with rheumatoid vasculitis (RV) who showed a good response to anti-tumor necrosis factor-a therapy. TNF-a antagonists should be considered as treatment in systemic RV, especially in patients who do not respond to immunosuppressive drugs or who have contraindication for such treatment.
authors.affiliation: Department of Rheumatology, Leiden University Medical Centre, The Netherlands. a.e.van_der_bijl@lumc.nl
authors.forename: A Egon
authors.initials: AE
authors.lastname: van der Bijl
authors.forename: Cornelia F
authors.initials: CF
authors.lastname: Allaart
authors.forename: Jeroen
authors.initials: J
authors.lastname: Van Vugt
authors.forename: Sjoerd
authors.initials: S
authors.lastname: Van Duinen
authors.forename: Ferdinand C
authors.initials: FC
authors.lastname: Breedveld
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014657:Vasculitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab